GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Change In Payables And Accrued Expense

StemRIM (TSE:4599) Change In Payables And Accrued Expense : 円0.00 Mil (TTM As of Jul. 2024)


View and export this data going back to 2019. Start your Free Trial

What is StemRIM Change In Payables And Accrued Expense?

StemRIM's Change In Payables And Accrued Expense for the quarter that ended in Jul. 2024 was 円0.00 Mil. It means StemRIM's Accounts Payable & Accrued Expense stayed the same from Apr. 2024 to Jul. 2024 .

StemRIM's Change In Payables And Accrued Expense for the fiscal year that ended in Jul. 2024 was 円0.00 Mil. It means StemRIM's Accounts Payable & Accrued Expense stayed the same from Jul. 2023 to Jul. 2024 .

StemRIM Change In Payables And Accrued Expense Historical Data

The historical data trend for StemRIM's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM Change In Payables And Accrued Expense Chart

StemRIM Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Change In Payables And Accrued Expense
Get a 7-Day Free Trial - - - - -

StemRIM Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

StemRIM Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

StemRIM Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of StemRIM's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

StemRIM Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
TSE:4880 TSE:4592 TSE:7096 TSE:7774 TSE:4978 TSE:4893 TSE:4575 TSE:4563 TSE:4579 TSE:2183 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085
Website
https://www.stemrim.com
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM Headlines

No Headlines